CHARLESTON, S.C., Sept. 7, 2010 (GLOBE NEWSWIRE) -- RevMed ("Revolutions Medical" or the "Company") (OTCBB:RMCP) has secured a binding 5 Year contract to produce 5M syringes/month of its 3mL fixed needle safety syringe with Medical Investment Group, LLC (MIG). MIG, a Massachusetts Limited Liability Company, will fulfill this obligation through its relationship with an internationally certified global medical device manufacturer. The manufacturer currently ships medical products throughout the world and is compliant with all major international standards including FDA, CE and Health Canada as well as those required in Japan, China and India. The factory is fully ISO compliant for medical device manufacturing and has comprehensive clean rooms, packaging and sterilization facilities. The factory has a current capability to scale up to 20 - 50 million syringes per month if required. First shipments for delivery are currently expected at the end of Q1/2011.
Final Documents will be signed on or before September 17, 2010. More specifics on the factory will also be disclosed at final signing. Rich Theriault, with whom the company has worked with for several years on both the RevVac syringe and the company's proprietary MRI software tools, will be managing this effort. He has a wealth of experience delivering numerous products into the medical device and high technology marketplace.
Rich Theriault states "The selection of this manufacturer with these stated capabilities provides Revolutions Medical with the ability to deliver the highest quality and cost effective product to the marketplace. With the strong performance history of this factory we can be assured of meeting the high demand for the product."
For additional information, please visit Revolutions Medical corporate website: www.revolutionsmedical.com/" target="_top" rel="nofollow">http://www.revolutionsmedical.com
Investor Resource Center
RevVac Safety Syringe Demonstration Video:
http://www.revolutionsmedical.com/videos/revac_directions_final.wmv
RevColor MRI Video:
http://www.revolutionsmedical.com/RevMed-ColorMRI-Video.php
To be added to the Revolutions Medical investor email list, please email www.globenewswire.com/newsroom/ctr%3Fd=191624%26l=13%26a=Skey%2540revolutionsmedical.com%26u=mailto%253ASkey%2540revolutionsmedical.com">Skey@revolutionsmedical.com with RMCP in the subject line.
Become a RevMed fan and follow the Company on Facebook -- visit www.Facebook.com/Revmed" target="_top" rel="nofollow">http://www.Facebook.com/Revmed
FORWARD-LOOKING STATEMENTS
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.